Original Research
Published on 12 Apr 2023
A single-arm phase II clinical trial of anlotinib combined with chemotherapy for the treatment of metastatic triple-negative breast cancer
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2023.1122294
- 3,640 views
- 9 citations





